Alabama 2025 Regular Session

Alabama Senate Bill SB273

Filed/Read First Time
 
Introduced
4/1/25  
Refer
4/1/25  
Report Pass
4/9/25  

Caption

Controlled substances; regulate sale of nonpsychoactive consumable hemp products by Agriculture Department; require sale of products only in pharmacies; add psychoactive derivatives of hemp as Schedule I drug

Impact

This legislation not only amends existing laws regarding the classification of certain cannabinoids but also aims to centralize the regulation of hemp products within the state. By contrasting the treatment of psychoactive cannabinoids as controlled substances while allowing the sale of tested nonpsychoactive cannabinoids, the bill seeks to protect consumers, particularly minors, from potential abuses surrounding psychoactive substances. Furthermore, the requirement that all consumable hemp products be tested prior to sale reinforces a commitment to product safety, aligning Alabama's regulations with best practices in hemp product management.

Summary

SB273 aims to regulate the sale of consumable hemp products by mandating that these products contain only nonpsychoactive cannabinoids derived from hemp cultivated within Alabama. It requires that such products be laboratory tested and sold exclusively in licensed pharmacies. The bill's intention is to create a controlled environment for the sale of hemp products while ensuring consumer safety through stringent testing protocols overseen by the Alabama State Board of Pharmacy. Under this bill, the Department of Agriculture and Industries will establish a comprehensive tracking program for these products from cultivation through to sale, known as a seed-to-sale tracking system.

Contention

Notably, the bill will repeal the existing provision that prohibits the sale of psychoactive cannabinoids to minors, which has raised concerns among certain advocacy groups about the potential for increased access to these substances. Critics assert that while the intention of the bill is to safeguard public health, it may inadvertently create loopholes. Supporters, on the other hand, emphasize the importance of regulating sales through licensed pharmacies, viewing it as a step towards a more mature and responsible hemp market in Alabama.

Companion Bills

No companion bills found.

Similar Bills

CT SB00970

An Act Concerning Cannabinoids, Hemp And Hemp Products.

AL SB1

Controlled substances; regulate sale of nonpsychoactive consumable hemp products by Agriculture Department; require sale of products only in pharmacies; add psychoactive derivatives of hemp as Schedule I drug

AL HB445

Cannabinoids found in hemp; licensure and regulation of sale of consumable cannabinoid products by Alcoholic Beverage Control Board imposed

CO SB164

Regulation of Lawful Tetrahydrocannabinol Beverages

AZ SB1702

Hemp-derived products; regulation

CT HB05350

An Act Concerning Cannabis, Hemp And Infused Beverage Regulation.

CT HB06855

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Drug Control And Cannabis And Hemp Regulation.

FL H0887

Medical Marijuana Use Registry Identification Cards for Veterans